Awards Nomination 20+ Million Readerbase
PMC/PubMed Indexed Articles
Bioavailability of Oral Hydrocortisone Corrected for Binding Proteins and Measured by LC-MS/MS Using Serum Cortisol and Salivary Cortisone
Crude Edible Fig ( Ficus carica) Leaf Extract Prevents Diethylstilbestrol (DES)-Induced DNA Strand Breaks in Single-Cell Gel Electrophoresis (SCGE)/Comet Assay: Literature Review and Pilot Study

View More »

Google Scholar citation report
Citations : 4890

Journal of Bioequivalence & Bioavailability received 4890 citations as per Google Scholar report

Journal of Bioequivalence & Bioavailability
Journal of Bioequivalence & Bioavailability peer review process verified at publons
Journal of Bioequivalence & Bioavailability
Indexed In
  • Academic Journals Database
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Ulrich's Periodicals Directory
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
View More
Useful Links
Share This Page
Journal Flyer
Journal of Bioequivalence & Bioavailability
Open Access Journals
View More

Jean-Pierre Gotteland

Jean-Pierre Gotteland

PregLem SA, Switzerland

Biography
  20+ years of experience in pharmaceutical R&D with extensive leadership experience in exploratory‐full development and regulatory across a range of therapeutic areas. Expert in all stage of drug development from discovery to post registration. Fully experienced with big pharma and start-up He has gathered, through various roles of increasing responsibilities (Medicinal Chemistry Head, Global Project Director, VP non clinical and manufacturing and head of R&D) a strong expertise in drug development by managing various research and preclinical/early/late stage drugs development programs, and cross-functional international development project teams in the area of neurology, autoimmune disorders, endocrinology, fertility, metabolism and oncology. He has developed a deep operational and strategic knowledge and expertise in drug development through the management of various drug development functions
Research Interest
 Neurology, autoimmune disorders, endocrinology, fertility, metabolism and oncology.